Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures	brain disorder, central nervous system disorder, epilepsy, focal epilepsy, nervous system disorder	Recruiting	Phase 2	2025-06-03		NCT06590896

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Ono Pharmaceutical Co., Ltd.	47

29 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Asahikawa Medical University Hospital	Hokkaido	Japan	1
Department of Neurology and Stroke Center, Southern Tohoku Clinic.	Fukushima	Japan	1
Ehime University Hospital	Ehime	Japan	4
Hiroshima University Hospital	Hiroshima	Japan	13
Itami City Hospital	Hyōgo	Japan	2
JA-Ibaraki Tsuchiura Kyodo General Hospital	Ibaraki	Japan	1
Jichi Medical University Hospital	Tochigi	Japan	5
Kagoshima University Hospital	Kagoshima	Japan	8
Koide Clinic of Epilepsy and Neurological Disorders	Osaka	Japan	2
Kumamoto Ezuko Rehabilitation Medical Center	Kumamoto	Japan	1
Medical Hospital, Tokyo Medical and Dental University	Tokyo	Japan	1
National Center of Neurology and Psychiatry	Tokyo	Japan	5
NHO Kure Medical Center and Chugoku Cancer Center	Hiroshima	Japan	1
NHO Nagasaki Medical Center	Nagasaki	Japan	1
NHO Shizuoka Institute of Epilepsy and Neurological Disorders	Shizuoka	Japan	1
NHO Yamagata National Hospital	Yamagata	Japan	1
Ochiai Brain Clinic	Saitama	Japan	1
Osaka University Hospital	Osaka	Japan	9
Sakurai Clinic	Shiga	Japan	1
Seirei Hamamatsu General Hospital	Shizuoka	Japan	1
Seirei Mikatahara General Hospital	Shizuoka	Japan	1
Shintokukai Nii Neurosurgery and Psychiatry Clinic	Osaka	Japan	1
St. Marianna University School of Medicine Hospital	Kanagawa	Japan	1
Tanaka Neurosurgical Clinic	Kagoshima	Japan	1
TMG Asaka Medical Center	Saitama	Japan	2

Clinical trials